ChengDu ShengNuo Biotec Co.,Ltd.
SHH: 688117.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yongjun Wen
- Employees
- 1,128
- Headquarters
- Chengdu, China
- IPO year
- 2021
- Market cap
- CN¥5.8B
- Website
- https://www.snbiopharm.com
Loading 688117…
Loading profile data…Frequently asked questions about 688117
What does ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) do?
ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. The company produces polypeptide APIs, tablets of solid preparation, bottles of freeze-dried powder injections, small-volume injections, pre-filled injections, and card type injections. ChengDu ShengNuo Biotec Co.,Ltd. was fou...
Where does 688117.SS trade?
ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) trades on the Shanghai Stock Exchange.
What sector is 688117.SS in?
ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of ChengDu ShengNuo Biotec Co.,Ltd.?
Yongjun Wen is the chief executive officer of ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS).
Where is ChengDu ShengNuo Biotec Co.,Ltd. headquartered?
ChengDu ShengNuo Biotec Co.,Ltd. is headquartered in China.
Does 688117.SS pay a dividend?
Yes — ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) paid a trailing twelve-month dividend of CNY 0.13 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688117.SS go public?
ChengDu ShengNuo Biotec Co.,Ltd. (688117.SS) completed its initial public offering in 2021.